ATE405578T1 - Tetrapeptid-derivat-kristalle - Google Patents

Tetrapeptid-derivat-kristalle

Info

Publication number
ATE405578T1
ATE405578T1 AT02799487T AT02799487T ATE405578T1 AT E405578 T1 ATE405578 T1 AT E405578T1 AT 02799487 T AT02799487 T AT 02799487T AT 02799487 T AT02799487 T AT 02799487T AT E405578 T1 ATE405578 T1 AT E405578T1
Authority
AT
Austria
Prior art keywords
derivative crystals
tetrapeptide derivative
methoxy
methyl
crystals
Prior art date
Application number
AT02799487T
Other languages
English (en)
Inventor
Koichi Miyazaki
Katsuyuki Keino
Arihiro Kanada
Nobuyoshi Minami
Original Assignee
Teikoku Hormone Mfg Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Hormone Mfg Co Ltd filed Critical Teikoku Hormone Mfg Co Ltd
Application granted granted Critical
Publication of ATE405578T1 publication Critical patent/ATE405578T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02799487T 2001-09-20 2002-09-19 Tetrapeptid-derivat-kristalle ATE405578T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001286674 2001-09-20

Publications (1)

Publication Number Publication Date
ATE405578T1 true ATE405578T1 (de) 2008-09-15

Family

ID=19109609

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02799487T ATE405578T1 (de) 2001-09-20 2002-09-19 Tetrapeptid-derivat-kristalle

Country Status (12)

Country Link
US (2) US7008928B2 (de)
EP (1) EP1428530B1 (de)
JP (1) JP4060794B2 (de)
KR (1) KR100901096B1 (de)
CN (2) CN1834088A (de)
AT (1) ATE405578T1 (de)
AU (1) AU2002362579B2 (de)
CA (1) CA2460956C (de)
DE (1) DE60228459D1 (de)
DK (1) DK1428530T3 (de)
ES (1) ES2309233T3 (de)
WO (1) WO2003026645A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006068768A2 (en) * 2004-11-24 2006-06-29 Hanna Skubatch Methods and compositions for treating conditions
US7557088B2 (en) * 2006-03-28 2009-07-07 Neopro Labs, Llc Methods and compositions for treating conditions
JP2010527377A (ja) * 2007-05-17 2010-08-12 ネオプロ ラブス，エルエルシー ペプチドの結晶形および非結晶形
WO2009012472A2 (en) * 2007-07-18 2009-01-22 Neopro Labs, Llc Methods and compositions for treating conditions
AU2016297786A1 (en) * 2015-07-24 2018-02-08 Noeleen Melody Quinstatin compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978744A (en) * 1989-01-27 1990-12-18 Arizona Board Of Regents Synthesis of dolastatin 10
DK0934950T3 (da) * 1991-08-09 2002-07-29 Teikoku Hormone Mfg Co Ltd Tetrapeptidderivat
US6034065A (en) * 1992-12-03 2000-03-07 Arizona Board Of Regents Elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10

Also Published As

Publication number Publication date
JP4060794B2 (ja) 2008-03-12
WO2003026645A1 (fr) 2003-04-03
KR100901096B1 (ko) 2009-06-08
DE60228459D1 (de) 2008-10-02
CA2460956A1 (en) 2003-04-03
DK1428530T3 (da) 2008-12-01
US20040254343A1 (en) 2004-12-16
US20050267041A1 (en) 2005-12-01
AU2002362579B2 (en) 2007-09-06
EP1428530B1 (de) 2008-08-20
CA2460956C (en) 2010-12-21
WO2003026645A8 (fr) 2004-09-30
KR20040036922A (ko) 2004-05-03
EP1428530A4 (de) 2005-03-30
CN1834088A (zh) 2006-09-20
US7385029B2 (en) 2008-06-10
JPWO2003026645A1 (ja) 2005-01-06
EP1428530A1 (de) 2004-06-16
US7008928B2 (en) 2006-03-07
EP1428530A8 (de) 2005-01-26
CN1309413C (zh) 2007-04-11
CN1556701A (zh) 2004-12-22
ES2309233T3 (es) 2008-12-16

Similar Documents

Publication Publication Date Title
MA26344A1 (fr) Derives 1,8-naphtyridine utilises comme antidiabetiques
EA200300566A1 (ru) Применение cci-779 в качестве противоопухолевого средства
EP1477482A4 (de) Neues phenylalaninderivat
CY1109718T1 (el) Παραγωγο 2-οξο-1-πυρρολιδινης και οι φαρμακευτικες του χρησεις
DK0639577T3 (da) Phosphonooxymethyl- eller methylthiomethylestere af taxanderivater som antitumormidler
NO20052884L (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
HUP0101439A2 (hu) A II antagonistát tartalmazó nyújtott felszabadulású készítmény, valamint eljárás ennek előállítására és alkalmazása
PA8477801A1 (es) (3s) tetrahidro-3-furanil (1s,2r)-3-[[4-aminofenil) sulfonil)] (isobutil) amino]-1-bencil-2-(fosfonooxi) propilcarbamato de calcio
EA200100411A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
NO20040100L (no) Nye forbindelser som anti-inflammasjons, immunmodulerende og anti-proliferative midler
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
IT1301801B1 (it) Procedimento per la preparazione di idrocarburi da gas di sintesi
DE69709407T2 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
BR0112375A (pt) Métodos de sìntese para aplidina e novos derivados antitumorais, métodos para fabrica-los e usá-los.
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
UY27287A1 (es) Sal citrato de 5,8,14-triazatetraciclo[10.3.1.0 2,11.0 4,9] hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de la misma
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
BR9813817A (pt) Análogos de hemiasterlina
BR9804027A (pt) Novos beta-ceto ésteres
DK1383742T3 (da) Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater
ATE405578T1 (de) Tetrapeptid-derivat-kristalle
ATE266029T1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
DE69936052D1 (de) N1 modifizierte glycopeptide
NO995676D0 (no) Isoftalamid derivat som gul polymorf
ATE236865T1 (de) 6-substituierte 3-methyloct-6-enole

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1428530

Country of ref document: EP